ConductScience.org, home

Paper54209

Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP.

Bonadonna G and 4 others. Cancer, 1975. Cited by 638 papers, by iCite.

Cite this record

ConductScience Library. Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP. Papers, record 54209. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/54209

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP.
PubMed
Journal
Cancer
PubMed
Year
1975
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
638
iCite
Relative citation ratio, by iCite
18
iCite
Revised in PubMed
2022-04-08
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bonadonna GG
2Zucali RR
3Monfardini SS
4De Lena MM
5Uslenghi CC

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hodgkin DiseaseMajor topic
Adolescent
Adult
Bleomycin
Child
Doxorubicin
Drug Therapy, Combination
Drug Tolerance
Female
Humans
Imidazoles
Male
Mechlorethamine
Middle Aged
Prednisone
Procarbazine
Prospective Studies
Vinblastine
Vincristine

Source PubMed

Download CSV of topics

Cited by128

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 638 citations.

PMIDTitleJournalYearIn PapersSource
42358815Prognostic Value of Spatial and Topological Features of Tumor Microenvironment in Classic Hodgkin Lymphoma.Oncol Res2026https://conductscience.org/library/papers/42358815PubMed
42352453Systemic Therapy for Advanced-Stage Hodgkin Lymphoma.Cancers (Basel)2026https://conductscience.org/library/papers/42352453PubMed
42166512Advanced Stage Hodgkin Lymphoma: A Review on Frontline Treatment Advances.Cancer J2026https://conductscience.org/library/papers/42166512PubMed
41790282Evolution of outcomes in autologous stem cell transplantation for hodgkin lymphoma over 2 decades at King Hussein cancer center.Ann Hematol2026https://conductscience.org/library/papers/41790282PubMed
41449752The importance of assessing the fitness of older patients with newly diagnosed diffuse large B-cell lymphoma and classic Hodgkin lymphoma.Br J Haematol2026https://conductscience.org/library/papers/41449752PubMed
41256864Expression and prognostic value of FKBP51 in Hodgkin lymphoma.Front Immunol2025https://conductscience.org/library/papers/41256864PubMed
41181846The national and subnational burden of Hodgkin Lymphoma (HL) in Italy from 1990 to 2023: results from the Global Burden of Disease Study 2023.EClinicalMedicine2025https://conductscience.org/library/papers/41181846PubMed
41063706Long-term cardiac morbidity in adolescent and young adult survivors of classical Hodgkin lymphoma: the British Columbia experience.Haematologica2026https://conductscience.org/library/papers/41063706PubMed
39202553The Effect of Diagnostic and Therapeutic Changes on the Survival of Hodgkin's Lymphoma Patients (1980-2019).Medicina (Kaunas)2024https://conductscience.org/library/papers/39202553PubMed
39034771Interim PET-guided ABVD or ABVD/escalated BEACOPP for newly diagnosed advanced-stage classic Hodgkin lymphoma (JCOG1305).Cancer Sci2024https://conductscience.org/library/papers/39034771PubMed
38893177Treatment Strategies in Advanced-Stage Hodgkin Lymphoma.Cancers (Basel)2024https://conductscience.org/library/papers/38893177PubMed
38791909Advances in Hodgkin Lymphoma Treatment: From Molecular Biology to Clinical Practice.Cancers (Basel)2024https://conductscience.org/library/papers/38791909PubMed
38359378Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma.J Clin Oncol2024https://conductscience.org/library/papers/38359378PubMed
37796339Impact of baseline and interim quantitative PET parameters on outcomes of classical Hodgkin Lymphoma.Ann Hematol2024https://conductscience.org/library/papers/37796339PubMed
37685994Incorporating Monoclonal Antibodies into the First-Line Treatment of Classical Hodgkin Lymphoma.Int J Mol Sci2023https://conductscience.org/library/papers/37685994PubMed
37565112A Review of Hodgkin Lymphoma in the Era of Checkpoint Inhibitors.Cureus2023https://conductscience.org/library/papers/37565112PubMed
37459116Evaluating Alkaline Phosphatase-Instructed Self-Assembly of d-Peptides for Selectively Inhibiting Ovarian Cancer Cells.J Med Chem2023https://conductscience.org/library/papers/37459116PubMed
37361649Isolated Hodgkin lymphoma of the intracranial dura: A case report and review of the literature.Clin Case Rep2023https://conductscience.org/library/papers/37361649PubMed
36941843A case of blood triglyceride increased induced by ABVD therapy for classical Hodgkin lymphoma.Leuk Res Rep2023https://conductscience.org/library/papers/36941843PubMed
36654739Genetic lesions and targeted therapy in Hodgkin lymphoma.Ther Adv Hematol2023https://conductscience.org/library/papers/36654739PubMed

See all 128 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/54209

GET https://conductscience.org/api/papers/v1/54209/cited_by?page=2